CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 27,700
-50 (-0.18%)
At close: Feb 27, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 355.43 billion as of February 27, 2026. Its market cap has increased by 56.16% in one year.
Market Cap
355.43B
Enterprise Value
334.31B
Revenue
2.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
27,700.00
Market Cap Chart
Since October 16, 2024, CellBion's market cap has increased from 263.06B to 355.43B, an increase of 35.11%. That is a compound annual growth rate of 24.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 355.43B | 17.37% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myung In Pharmaceutical LTD. | 946.08B |
| Samyang Biopharm | 758.46B |
| ImmuneOncia Therapeutics | 628.18B |
| HEM Pharma | 574.46B |
| DAE HWA Pharmaceutical | 263.98B |
| NOVAREX | 258.98B |
| Vivozon Pharmaceutical | 211.08B |
| Organoidsciences | 210.42B |